The National Allergy Centre of Excellence–Addressing Australia's Allergy Burden
Clinical & Experimental Allergy · 2026-11 · 56 (11) · 1385-1396
DOI: 10.1111/cea.70392 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical & Experimental Allergy, online erschienen am 31.07.2026. Verfasst von A Young und 23 weiteren Autor:innen. Beteiligte Einrichtung: Murdoch Children's Research Institute, Parkville, Victoria, Australia. Hauptthemen laut MEDLINE: Hypersensitivity, Food Hypersensitivity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Government, Department of Health, Disability and Ageing, Victorian Government's Operational Infrastructure Support Program, Philanthropic donations.
Abstract (Originalsprache)
Australia has one of the highest rates of food allergy, anaphylaxis hospital admissions and anaphylaxis fatalities worldwide. These trends and sustained advocacy prompted a 2019 Parliamentary Inquiry into Allergies and Anaphylaxis. Among 250 submissions, the Centre for Food Allergy Research called for a national research‐coordinating centre and comprehensive allergy research funding. In response to the inquiry, the Australian Government funded the National Allergy Centre of Excellence (NACE) in 2022, and its partner organisation, the National Allergy Council (NAC), to improve health, save lives and reduce the national burden of allergic disease. Here we describe the establishment and early impacts of the NACE. The NACE was established to build critical national research infrastructure and collaboration to transform consumer‐centred allergy care. Four interconnected Pillars underpin the plan of action: (1) Transforming Allergy Care, codesigning national trials and embedded clinical research to address knowledge and practice gaps; (2) BioRepository and Discovery, developing Australia's first national Allergy BioRepository (ALBI) to support data‐driven discovery; (3) Evidence and Translation, providing living evidence surveillance and synthesis to accelerate translation into policy and practice; and (4) Training and Innovation, building workforce capacity through postgraduate scholarships and fellowships. In just 3 years, the NACE has become a global exemplar, secured further funding and demonstrated excellence in high‐impact research, rapid translation into policy and practice, and improved outcomes for people living with allergic disease. The NACE has united over 500 drug, food, insect and respiratory allergy experts. Over 1500 individuals with allergies are enrolled in five research programs initiated in clinical care, including more than 500 families in a national, standardised peanut oral immunotherapy program (ADAPT) and NACE‐led evaluation study. The ALBI design and build are well‐advanced, and over 5000 academic articles have been assessed through Australia's first drug and food allergy living evidence collections, underpinning clinical guidelines, public health programs and resources. The NACE has been recognised as an European Academy of Allergy and Clinical Immunology Advanced Research Centre and a World Allergy Organisation Center of Excellence. In December 2025, the NACE‐NAC partnership secured further Federal Government funding to continue driving national impact.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Murdoch Children's Research Institute, Parkville, Victoria, Australia.
- National Allergy Centre of Excellence, Parkville, Victoria, Australia.
- Centre for Food Allergy Research, Parkville, Victoria, Australia.
- The University of Queensland, Brisbane, Queensland, Australia.
- The Children's Hospital at Westmead, Westmead, New South Wales, Australia.
- The University of Sydney, Camperdown, New South Wales, Australia.
ORCID-Profile: C J Hornung, M D O'Sullivan, J Trubiano, S van Nunen, K P Perrett
Förderung
- Australian Government, Department of Health, Disability and Ageing
- Victorian Government's Operational Infrastructure Support Program
- Philanthropic donations
Zitieren
APA
Young, A., Koplin, J. J., Campbell, D. E., Davies, J. M., Edmund, H., Jamieson, T., Hornung, C. J., O'Farrell, T., West, D., Kayes, E., Gray, L. A., Peters, R. L., Gamble, L., Gwynne, K., Lee, J., Lucas, M., Katelaris, C. H., O'Sullivan, M. D., Palmer, D. J., …, & Perrett, K. P. (2026). The National Allergy Centre of Excellence–Addressing Australia's Allergy Burden. Clinical & Experimental Allergy, 56(11), 1385-1396. https://doi.org/10.1111/cea.70392
Vancouver
Young A, Koplin JJ, Campbell DE, Davies JM, Edmund H, Jamieson T, et al. The National Allergy Centre of Excellence–Addressing Australia's Allergy Burden. Clinical & Experimental Allergy. 2026;56(11):1385-1396. doi:10.1111/cea.70392
BibTeX
@article{Young2026,
author = {Young, A and Koplin, J J and Campbell, D E and Davies, J M and Edmund, H and Jamieson, T and Hornung, C J and O'Farrell, T and West, D and Kayes, E and Gray, L A and Peters, R L and Gamble, L and Gwynne, K and Lee, J and Lucas, M and Katelaris, C H and O'Sullivan, M D and Palmer, D J and Trubiano, J and van Nunen, S and Vale, S L and Wanandy, T and Perrett, K P},
title = {The National Allergy Centre of Excellence–Addressing Australia's Allergy Burden},
journal = {Clinical & Experimental Allergy},
year = {2026},
volume = {56},
number = {11},
pages = {1385--1396},
doi = {10.1111/cea.70392}
}
EUVIMED